1. Introduction {#s0005}
===============

The liver plays a crucial biological role in metabolism and detoxification ([@b0070]). Hepatic injury may be triggered by alcohol consumption, viral infections and a myriad of xenobiotics. The chemical agent carbon tetrachloride (CCl~4~) mediates redox-sensitive hepatotoxicity via generation of free radicals and subsequent lipid peroxidation ([@b0150], [@b0305]). Carbon tetrachloride has been used to simulate hepatic injury in laboratory animals and is a widely accepted *in vivo* model to study the pharmacological effects of hepatoprotective molecules ([@b0155], [@b0350]). Due to various side-effects of conventional drugs, there has been a renewed interest in exploiting the biological effects of nutraceuticals. Various bioactive molecules derived from natural sources such as flavonoids and catechins possess hepatoprotective effects ([@b0200]). Consumption of fruits and vegetables may, thus, be therapeutically beneficial during the course of both acute and chronic liver injury.

The tropical fruit sapodilla (*Manilkara achras* (Mill) Fosb., syn *Achras sapota* L.) family: Sapotaceae is rich in nutrients and minerals, and is widely consumed fresh but its pulp is also incorporated into various culinary preparations ([@b0135], [@b0290]). Sapodilla is a good source of vitamins and minerals including vitamin A, vitamin B complex, vitamin C, carotene, calcium, potassium, magnesium and phosphorus ([@b0295]). The leaves and fruits of sapodilla have been used in traditional medicine to treat several diseases ([@b0115], [@b0130], [@b0210]). Sapodilla is enriched with phytochemicals such as catechin, epicatechin, leucocyanidin, leucodelphinidin, leucopelargonidin, and gallic acid ([@b0165], [@b0335]). These bioactive constituents confer sapodilla with robust antioxidant properties ([@b0170], [@b0180], [@b0285]). Sapodilla was shown to exhibit anti-bacterial ([@b0245]), anti-fungal ([@b0195]), antiglycative ([@b0275]), hypocholesterolemic ([@b0075]), anti-cancer ([@b0215]), and anti-parasitic ([@b0240]) effects. Sapodilla was recently shown to trigger apoptosis in various cell lines by activating the mitochondrial pathway ([@b0300]). In addition to these beneficial effects, sapodilla plums contain allergen proteins ([@b0090]), which may induce food-associated allergies ([@b0095]). Despite these pharmacological effects of sapodilla, the modulatory effects of sapodilla on liver injury remain elusive.

In the present study, we investigated the effect of lyophilized sapodilla extract (LSE) on various markers of liver damage and elucidated the role of redox mechanisms in LSE-mediated hepato-protection in CCl~4~-induced hepatic injury in rats.

2. Materials and methods {#s0010}
========================

2.1. Plant material and dosage preparation {#s0015}
------------------------------------------

The fresh sapodilla fruits were purchased from a local vegetable and fruit vendor. The fruits were thoroughly washed with tap water, cut into small pieces, seeds removed and the juice obtained using an electric blender. The juice was lyophilized to get the dry powder using a lyophilizer. The freeze dried powder (LSE) was dissolved in distilled water and used in all the experiments, except for measuring the free radical scavenging and antioxidant activities, where methanolic extracts were used.

2.2. Animals {#s0020}
------------

Wistar albino male rats, 180 ± 20 g were used in this study. The animals were caged individually in hygienic conditions and kept in a controlled environment with a 12 h light--dark cycle at 22 ± 3 °C for a week before starting the experiment. The animals had free access to purina chow diet and water *ad libitum*. The study protocol was approved by the Institutional Review Board (No. RAKMHSU-REC-08-2019-F-P).

2.3. Chemicals and reagents {#s0025}
---------------------------

All chemicals were procured from Sigma (Sigma-Aldrich, St. Louis, MO, USA). United and/or Roche Diagnostics kits (AST, ALT, ALP, Total Proteins, Cholesterol, Triglycerides, HDL, LDL, etc.) were used to determine the biochemical parameters on Reflotron Plus Analyzer (Roche Diagnostics GmbH, Mannheim, Germany) and on a Shimadzu UV mini 1240 spectrophotometer (Shimadzu Europe, Milano, Italy) for the measurement of MDA, NP-SH, and total proteins.

2.4. Carbon tetrachloride-induced hepatic toxicity and drug treatment {#s0030}
---------------------------------------------------------------------

Five groups (I--V) of animals (N = 6) were used. Group I served as normal control and received all the vehicles via respective routes. Group II received only carbon tetrachloride (CCl~4~) as intoxicated control. Groups III and IV were assigned as test groups. Group III and IV were pre-treated with LSE at doses of 250 and 500 mg/kg orally, daily for 17 days, whereas group V was pre-treated with silymarin (SIL) at a dose of 10 mg/kg b.w. orally, for 17 days; this group was used as a positive control. A dosage of 250 mg/kg for rat will be equivalent to 43 mg/kg for human according to dose conversion based on metabolically active mass of animals ([@b0120]). Silymarin is a mixture of flavonolignans extracted from the milk thistle \[Silybum marianum (L.) Gaertneri\] and is a potent hepatoprotective agent ([@b0080]). At the 16th day, groups II--V received CCl~4~ in liquid paraffin (1:1) at a dose of 1.25 mL/kg/rat intraperitoneally. After 24 h, following CCl~4~ challenge, rats were sacrificed and blood was collected by cardiac puncture, serum separated and stored at −80 °C until analysis. The liver was removed for biochemical and histological assessment.

2.5. Analysis of biomarkers for liver function {#s0035}
----------------------------------------------

The serum biomarkers of liver function including alanine aminotransferase (ALT), aspartate aminotransferase (AST), γ-glutamyl transferase (GGT), alkaline phosphatase (ALP), and bilirubin were analysed by commercial kits supplied by United Diagnostic Industry, KSA.

2.6. Determination of serum lipids {#s0040}
----------------------------------

Serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL), and triglycerides (TG) were determined by the Roche diagnostics kits (Roche Diagnostics GmbH, Mannheim, Germany) using the previously reported protocols. The levels of low-density lipoprotein cholesterol (LDL) and very low-density lipoprotein cholesterol (VLDL) were computed using the following equations: LDLC = TC-HDL-VLDL; VLDL = TG/5.27.

2.7. Determination of malondialdehyde (MDA) {#s0045}
-------------------------------------------

A modified method of [@b0330] was used. The liver was homogenized (10% w/v, 1 mL) in 0.15 M KCl at 4 °C. After incubating (37 °C for 3 h) the homogenate, equal volume of trichloroacetic acid (TCA, 10%) was added and the mixture was centrifuged at 800*g* for 10 min. An aliquot (1 mL) was then mixed with equal volume of 0.67% thiobarbituric acid (TBA) and the tubes were kept in a boiling water bath for 10 min. After cooling at room temperature, the contents were diluted with 1 mL distilled water, and the absorbance was recorded at 535 nm. The level of MDA (nmol/g wet tissue) was calculated using the equation:$$\mathit{MDA}{(nmol/g)} = \frac{\mathit{Abs}\; of\; sample \times dilution\; factor}{\mathit{Slope}\; of\; standard\; curve}$$

2.8. Analysis of nonprotein sulfhydryls (NP-SH) {#s0050}
-----------------------------------------------

The method of [@b0265] was used for the estimation of NP-SH levels in rat liver. The tissue was homogenized in ice-cold ethylenediaminetetraacetic acid (EDTA, 0.02 M). The homogenate (1 mL) was mixed with equal volume of distilled water and 0.25 mL of trichloroacetic acid (50%), contents shaken for 10 min and centrifuged. An aliquot of supernatant (0.5 mL) was mixed with 1.0 mL ofTris buffer (0.4 M, pH 8.9) and 0.25 mL of 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB). After shaking the mixture, the absorbance was read at 412 nm against a reagent blank. The level of NP-SH in liver tissue was calculated according to the following equation:$$\mathit{NP} - SH{(nmol/g)} = \frac{\mathit{Abs}\; of\; sample \times Conc\; of\; s\tan dard(nmol/g) \times dilution\; factor}{\mathit{Abs}\; of\; standard}$$

2.9. Analysis of total proteins (TP) {#s0055}
------------------------------------

Serum TP was measured using a commercial kit (Crescent Diagnostics, Jeddah, Saudi Arabia) according to manufacturer's instructions. The Absorbance of coloured complex at 546 nm was directly proportional to total protein levels in the sample, which were calculated using the equation: Absorbance of sample/Absorbance of standard) × concentration of standard.

2.10. Free radical scavenging assay {#s0060}
-----------------------------------

The ability of LSE to scavenge the stable free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH) was evaluated as reported earlier ([@b0030]). The LSE was re-dissolved in methanol and serial concentrations (10--1000 μg/mL) of the extract, 125 μL DPPH (1.0 mM) and 375 μL solvent (methanol) were added. The contents were incubated at 25 °C for 30 min and the decrease in absorbance was measured at 517 nm. The free radical scavenging activity of LSE was calculated from the following equation:$$\%\; of\; radical\; Scavenging\; activity = \frac{\mathit{Ab}s_{\mathit{control}} - Abs_{\mathit{sample}}}{\mathit{Ab}s_{\mathit{control}}} \times 100$$

2.11. β-Carotene-linoleic acid assay {#s0065}
------------------------------------

We used β-carotene bleaching method ([@b0185]) for measuring the antioxidant activity of LSE. One milliliter of a 0.2 mg/mL β-carotene solution was mixed with 0.02 mL of linoleic acid and 0.2 mL of Tween-20 followed by removal of organic solvent (chloroform) by heating at 40 °C in a rotary evaporator. The residual mixture was diluted with 10 mL of distilled water and briefly mixed to form an emulsion. The blank was prepared without using β-carotene. The control contained 0.2 mL of 80% methanol instead of extract. An aliquot (5 mL) of the emulsion was mixed with 0.2 mL of sample at the concentration of 1.0 mg/mL. Rutin (1.0 mg/mL) was used as a positive control. The tubes were kept in a water bath at 40 °C for 2 h and the absorbance was recorded at 470 nm at 15 min intervals, using a UV--visible spectrophotometer (UV mini-1240, Shimadzu, Japan). The following equation was used to calculate the percent antioxidant activity:% antioxidant activity = 1 − (Abs~0~ − Abs~t~)/(Abs°~0~ − Abs°~t~) × 100

where Abs~0~ and Abs°~0~ are absorbance values recorded at zero time for sample and control, respectively. Abs~t~ and Abs°~t~ are the absorbance readings for sample and control, respectively, measured at 120 min.

2.12. Histopathology {#s0070}
--------------------

The liver tissue samples were fixed in 10% neutral buffered formalin for 24 h and processed using a tissue processor. The processed tissue was then embedded in paraffin blocks and sections (5 µm thickness) were cut by a rotary microtome. Sections were stained with haematoxylin and eosin (H & E) and examined under a light microscope for histopathological changes.

2.13. Statistical analysis {#s0075}
--------------------------

The data were analysed by one-way analysis of variance (ANOVA) followed by post-hoc Dunnett's multiple comparison test, using the statistical package, SPSS version 10. P values less than 0.05 were considered significant.

3. Results {#s0080}
==========

We explored the effect of LSE on serum biomarkers indicative of hepatic injury. Administration of CCl~4~ (1.25 mL/kg) induced a significant elevation of the serum biomarkers AST, ALT, GGT, ALP and bilirubin ([Table 1](#t0005){ref-type="table"}). This effect was significantly blunted in rats administered with LSE (250 and 500 mg/kg) in a dose-dependent manner ([Table 1](#t0005){ref-type="table"}). The positive control silymarin-treated group similarly showed a significant reduction in CCl~4~-triggered upregulation of serum biomarkers of liver injury ([Table 1](#t0005){ref-type="table"}). These data suggest that LSE administration mediates hepatoprotective effects against chemically-induced liver damage.Table 1Effect of lyophilized sapodilla extract (LSE) on serum marker enzymes in control and experimental rats.TreatmentAST (U/L)ALT (U/L)GGT (U/L)ALP (U/L)Bilirubin (mg/dL)Control91.71 ± 4.2033.86 ± 2.303.48 ± 0.34332.1 ± 10.060.54 ± 0.01CCl~4~296.0 ± 9.76\*\*236.33 ± 7.85\*\*11.71 ± 0.75\*\*560.1 ± 10.28\*\*2.42 ± 0.05\*\*LSE-250 + CCl~4~287.0 ± 8.00\*\*233.50 ± 2.88\*\*12.03 ± 0.41\*\*522.0 ± 7.04\*\*\#2.11 ± 0.12\*\*\#LSE-500 + CCl~4~291.8 ± 5.51\*\*202.16 ± 4.17\*\*\#9.46 ± 0.24\*516.5 ± 8.92\*\*\#2.06 ± 0.14\*\*\#Silymarin-10 + CCl~4~196.6 ± 6.44\*\#\#107.46 ± 4.79\*\#\#5.10 ± 0.13\#\#413.8 ± 9.20\*\#\#1.02 ± 0.06\*\#\#[^1]

Administration of CCl~4~ significantly increased serum cholesterol, triglycerides, LDL and VLDL while reducing serum HDL ([Table 2](#t0010){ref-type="table"}). These effects were significantly and dose-dependently mitigated by LSE. Similar to LSE, the positive control silymarin significantly curtailed CCl~4~-induced changes in serum lipid profile ([Table 2](#t0010){ref-type="table"}), thus, providing additional evidence of the hepatoprotective effects of LSE on CCl~4~--triggered hepatocellular damage.Table 2Effect of lyophilized sapodilla extract (LSE) on serum lipoproteins in control and experimental rats.TreatmentCholesterol (mg/dL)Triglycerides (mg/dL)HDL (mg/dL)LDL (mg/dL)VLDL (mg/dL)Control89.6 ± 3.0365.9 ± 3.3653.40 ± 2.4423.00 ± 2.4413.19 ± 0.67CCl~4~200.3 ± 8.63\*\*157.1 ± 4.23\*\*26.80 ± 1.01\*142.10 ± 8.69\*\*31.43 ± 0.84\*LSE-250 + CCl~4~151.5 ± 5.59\*\#\#129.8 ± 4.26\*\#39.85 ± 2.22\#\#86.68 ± 6.81\*\#\#25.96 ± 0.85\*\#LSE-500 + CCl~4~123.0 ± 3.72\#\#101.4 ± 5.02\*\#\#42.03 ± 1.45\#\#60.68 ± 5.01\*\#\#20.28 ± 1.00\#\#Silymarin-10 + CCl~4~130.8 ± 6.17\#\#131.6 ± 5.05\*\#\#36.91 ± 1.13\#\#67.58 ± 6.48\*\#\#26.33 ± 1.01\*\#[^2]

In view of the modulatory effect of LSE on CCl~4~-induced hepatic injury, an additional series of experiments was performed to elucidate the underlying mechanism. We determined whether LSE treatment affected CCl~4~-stimulated redox imbalance in the rat liver. We estimated hepatic MDA levels. As illustrated in [Fig. 1](#f0005){ref-type="fig"}, CCl~4~ treatment significantly increased hepatic MDA levels, an effect that was significantly and dose-dependently curtailed by LSE and the positive control silymarin. These results suggest the participation of antioxidant effects of LSE in ameliorating CCl~4~-induced liver damage.Fig. 1Effect of lyophilized sapodilla extract (LSE) on liver tissue lipid peroxidation (MDA) levels in carbon tetrachloride (CCl~4~) intoxicated rats. \*P \< 0.05, \*\*P \< 0.01 and \*\*\*P \< 0.001 versus control; \#P \< 0.01 and \#\#P \< 0.001 versus CCl~4~ only group.

To corroborate the aforementioned antioxidant effects of LSE on the hepatic tissue, we determined hepatic non-protein sulfhydryl levels. As depicted in [Fig. 2](#f0010){ref-type="fig"}, CCl~4~ treatment significantly reduced NP-SH levels in rat liver, an effect significantly attenuated by both LSE and silymarin, suggesting that LSE-induced hepatoprotection in CCl~4~-treated rats is mediated by its antioxidant effects. Further experiments addressed the effect of LSE on CCl~4~--induced decrease in total hepatic protein. As shown in [Fig. 3](#f0015){ref-type="fig"}, CCl~4~-triggered decreased hepatic protein levels were significantly and dose-dependently reversed by both LSE and silymarin treatment.Fig. 2Effect of lyophilized sapodilla extract (LSE) on liver tissue non-protein sulfhydryl (NP-SH) levels in carbon tetrachloride (CCl~4~) intoxicated rats. \*P \< 0.01 versus control; \#P \< 0.05 versus CCl~4~ only group.Fig. 3Effect of lyophilized sapodilla extract (LSE) on liver tissue total protein levels in carbon tetrachloride (CCl~4~) intoxicated rats. \*P \< 0.05, \*\*P \< 0.01 and \*\*\*P \< 0.001 versus control; \#P \< 0.05 and \#\#P \< 0.01 versus CCl~4~ only group.

The potential antioxidant activity of the LSE was investigated on the basis of DPPH radical scavenging activity and of inhibition of linoleic acid oxidation. As demonstrated in [Table 3](#t0015){ref-type="table"}, LSE was able to reduce the stable free radical DPPH (purple) to the yellow-colored DPPH-H in a concentration dependent manner. In β-carotene/linoleic acid antioxidant potential test, LSE was also able to inhibit the discoloration of β-carotene at a concentration of 1.0 mg/mL, showing the total antioxidant capacity as 74.4% as compared with the positive control, rutin (90.9%) ([Table 3](#t0015){ref-type="table"}).Table 3Free radical scavenging activity and antioxidant activity of the methanolic extract of sapodilla as compared to other antioxidants.Radical scavenging activity (%)Total antioxidant activity (%)10 (µg/mL)50 (µg/mL)100 (µg/mL)500 (µg/mL)1000 (µg/mL)1000 (µg/mL)Sapota7.828.554.171.285.574.4Ascorbic acid16.880.290.192.894.9--Rutin\*----------90.9[^3]

The results of histopathological assessment of hepatic tissues ([Fig. 4](#f0020){ref-type="fig"}) correlated with the above mentioned biochemical findings. Group A (control group) showed normal hepatic tissues. Group B (CCl~4~-intoxicated rat) revealed severe fatty degeneration, ballooning, and inflammatory cell infiltration in addition to massive hemorrhages. Group C (250 mg/kg LSE) showed focal degeneration concomitant with vacuolization and patchy inflammatory cells infiltrations were observed. Group D (500 mg/kg LSE) showed insignificant change in the form of mild cellular degeneration. Group E (10 mg/kg silymarin) had normal appearance of hepatocytes population and portal triad architecture.Fig. 4Histopathology of livers of rats from different treatment groups. (A) Control group showing a normal structure; (B) CCl~4~-intoxicated rat showing abundant fatty deposition and ballooning (blue arrow), inflammatory cells infiltration (black arrow) and massive hemorrhage (red arrow); (C) LSE (250 mg/kg) group showing mild steatosis, focal vacuolization (blue arrow) and inflammatory cells (black arrow); (D) LSE (500 mg/kg) group showing some mild pathological changes; (E) silymarin (10 mg/kg) showing normal appearance of hepatocytes. Scale bar = 100 µm.

4. Discussion {#s0085}
=============

Nonalcoholic fatty liver disease (NAFLD) refers to a wide spectrum of liver damage that spans from mild steatosis to nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis ([@b0140]). This disease is a major cause of elevation of liver enzymes. The global prevalence of NAFLD is about 25% and continues to raise worldwide ([@b0190]). A recent Swiss study has reported that the incidence of advanced liver disease is estimated to increase by approximately 40% by 2030 ([@b0085]). It is important to note that NAFLD is an independent risk factor for drug-related acute hepatitis; that means NAFLD patients are at higher risk for acute hepatotoxicity due to medications for other illnesses ([@b0310]). An animal study also showed that nonalcoholic fatty liver sensitizes rats to CCl4 hepatotoxicity ([@b0065]). Thus, searching for novel prophylactic and therapeutic hepato-protective agents with no side effects is of prime concern.

In this study we used CCl~4~ treated rat model of liver damage. Besides elevating the levels of liver enzymes, blood glucose, non-esterified fatty acids in the serum and glycogen in liver, CCl~4~ also significantly decreases phosphorylase activity in liver and increases carbohydrate intolerance and insulin resistance ([@b0260]). Administration of CCl~4~ causes liver steatosis ([@b0050]) and therefor it has been used to develop experimental models of NAFLD ([@b0110], [@b0045]) and NASH ([@b0325], [@b0225]); the latter condition is a type of NAFLD with inflammation and liver cell damage along with fat accumulation. A mass spectrometry study showed that the damage to rat liver tissue by CCl~4~ is accompanied with the alterations in diacylglycerols, cholesterol and fatty acids, such as linoleic and oleic acids ([@b0220]).

This study showed that exposure of CCl~4~ significantly elevated the levels of serum aminotransferases and other liver enzymes indicating the hepatic damage and severe liver dysfunction caused by CCl~4~ ([Table 1](#t0005){ref-type="table"}). Both AST and ALT are important biomarkers of liver function ([@b0020], [@b0010]). The impairment of liver function in CCl~4~ alone treated rats was accompanied with dyslipidemia ([Table 2](#t0010){ref-type="table"}). Treatment with sapodilla significantly reversed the adverse effects of CCl~4~ on liver function as well as serum lipid profile suggesting the pharmacological potential of sapodilla extract in liver disease. The flavonoids were previously shown to possess robust lipid-lowering effects ([@b0025]). It is likely that the hypocholesterolmic effects of sapodilla are mediated by bioactive constituents such as flavonoids.

The hepatoprotective effect of sapodilla was also confirmed by histopathology. Administration of CCl~4~ caused severe fatty degeneration, ballooning and inflammatory cell infiltration in rat liver ([Fig. 4](#f0020){ref-type="fig"}B). Fat accumulation is a hallmark of NAFLD that may lead to fibrosis, necrosis or even cirrhosis. Hepatocellular ballooning is considered as an important histological parameter in the diagnosis of NASH and is indicative of a greater risk of disease progression ([@b0035]). Observation of human liver biopsies has confirmed that accumulation of inflammatory cells such as macrophages is associated with progressive NAFLD ([@b0340]). Treatment of rats with sapodilla extract reversed the CCl~4~-induced structural changes, indicating the regeneration of hepatic tissue.

Administration of CCl~4~ alone significantly increased MDA ([Fig. 1](#f0005){ref-type="fig"}) and depleted NP-SH ([Fig. 2](#f0010){ref-type="fig"}) levels in rat liver. Both MDA and NP-SH are important indicators of oxidative stress ([@b0255], [@b0125], [@b0005], [@b0315], [@b0015]). Treatment of rats with sapodilla extract as well as the antioxidant silymarin significantly reversed CCl~4~-induced oxidative stress. Previous studies have shown that CCl~4~ is capable of generating highly reactive free radicals that lead to oxidative stress ([@b0100]) and inflammation ([@b0320]). Several investigators have implicated oxidative stress ([@b0055]) and proinflammatory cytokines ([@b0235], [@b0175]) in fatty liver disease. Whereas, compounds with antioxidant ([@b0345], [@b0270]) and anti-inflammatory ([@b0205]) properties have shown beneficial effects in protecting animals against chemical-induced liver damage. Treatment with ASB14780, a phospholipase A2 (PLA2) inhibitor, markedly ameliorated liver injury and hepatic fibrosis in CCl~4~ treated mice ([@b0110]). Reduced production of eicosanoids in the liver suppressed the inflammation and oxidative stress resulting in the protection against chemical-induced liver injury in mice ([@b0040]). In mouse models of acute CCl~4~ and chronic methionine-choline-deficient (MCD) diet-induced hepatic injuries, treatment with anti-CXCL16 chemokine not only significantly decreased the infiltration of inflammatory macrophages into the liver but also reduced the levels of proinflammatory cytokines and reversed steatosis ([@b0340]).

Our results showed a dose-dependent free radical scavenging activity of sapodilla extract ([Table 3](#t0015){ref-type="table"}). The anti-inflammatory activity of sapodilla has been reported earlier ([@b0160]). Mechanistically, the reported biological effects of sapodilla are mediated by its bioactive constituents. Of the various polyphenols characterized from sapodilla extracts, methyl 4-O-galloylchlorogenate was shown to possess the highest antioxidant activity ([@b0165]). Sapodilla is also rich in proanthocyanidins ([@b0335]), which have been shown to possess a variety of beneficial health effects including hepatoprotection ([@b0060], [@b0280]), an effect that could be attributed to its anti-apoptotic effect in hepatic cells ([@b0250]). [@b0230] have shown the beneficial effects of apricot on CCl~4~-induced liver steatosis and damage, due to its high radical-scavenging capacity antioxidant contents (beta-carotene and vitamin), suggesting that dietary intake of apricot can reduce the risk of liver steatosis and degeneration caused by free radicals. Exposure of CCl~4~ caused significant decrease in total protein levels ([Fig. 3](#f0015){ref-type="fig"}) that may be attributed to CCl~4~-induced decrease in several amino acids including the essential amino acids, leucine and isoleucine ([@b0145]). Supplementation of branched chain amino acids (BCAA) has been shown to modify CCl4-induced cirrhosis in rats ([@b0105]).

In conclusion, the present study reveals hepatoprotective effect of lyophilized sapodilla extracts against CCl~4~ induced hepatic damage, an effect, at least in part, mediated by its antioxidant activity. Since the liver injury caused by CCl~4~ in rats mimics the NAFLD seen in humans, the dietary consumption of sapodilla fruit may have beneficial effects in prophylaxis or regeneration of hepatic tissue. This study was conducted in experimental animals and its relevance to humans requires additional clinical studies.
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[^1]: All values represent mean ± SEM. \*P \< 0.01 and \*\*P \< 0.001 verses control; \#P \< 0.05 and \#\#P \< 0.01 versus CCl~4~ only group.

[^2]: All values represent mean ± SEM. \*P \< 0.01 and \*\*P \< 0.001 verses control; \#P \< 0.05 and \#\#P \< 0.01 versus CCl~4~ only group.

[^3]: \*Rutin is a plant pigment (flavonoid) with potent antioxidant properties. It was used as a positive control.
